Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
33%
Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
completed133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

NCT04807842
completedphase_1

Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

NCT03116022
unknownphase_2

Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause

NCT06176820

Clinical Trials (3)

Showing 3 of 3 trials
NCT04807842Not Applicable

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Recruiting
NCT03116022Phase 1

Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

Completed
NCT06176820Phase 2

Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3